Objective: To assess the effect of supplementation with an antioxidant forti®ed margarine on the body's antioxidant status and on parameters of oxidative damage to lipids. Design: Single blind, placebo controlled trial, two treatment groups balanced for sex, age and Quetelet Index. Setting: Unilever Research Laboratorium, The Netherlands. Subjects: Thirty-one healthy adult volunteers accomplished the study. Volunteers were recruited among inhabitants of the surrounding area of the research laboratory. Interventions: Volunteers consumed during the four weeks either 15 g/d of an antioxidant forti®ed margarine (providing 121 mg vitamin C, 31 mg vitamin E, 2.7 mg a-carotene and 5.3 mg b-carotene) or an ordinary margarine. Fasting blood samples were taken before and at the end of the study. Results: Consumption of the antioxidant forti®ed margarine signi®cantly increased the levels of the supplied antioxidants in plasma and LDL as compared to the changes found after consumption of the control margarine, with the largest increases found in LDL levels of a-carotene (15.5-fold increase, 95% CI: 8.4±27.8-fold) and bcarotene (4.3-fold increase, 95% CI: 2.2±7.9-fold). This increased antioxidant status in the antioxidant forti®ed margarine group resulted in a signi®cantly increased total antioxidant activity of LDL and resistance of LDL to oxidation (lag time and rate of oxidation) as compared to baseline but not in comparison to the changes found in the control group. Conclusion: Consumption of moderate doses of vitamin E, vitamin C, a-carotene and b-carotene, supplied in a full-fat margarine and consumed as part of a normal diet, effectively increases the blood levels of these antioxidants.
Introduction
Elevated plasma concentrations of low-density lipoprotein (LDL) cholesterol are associated with accelerated atherogenesis and increased risk of cardiovascular disease (Lipid Research Clinics Program, 1984) . There is increasing evidence from experimental studies that in addition to the level of LDL-cholesterol, also the susceptibility of the LDL particle to oxidative modi®cation may play a crucial role in atherogenesis (Steinberg et al, 1989; Witztum & Steinberg, 1991; . As a consequence it is plausible that antioxidants act in preventing atherosclerosis. Several epidemiological studies have indeed indicated that a higher intake or increased plasma levels of the antioxidants vitamin E, vitamin C and b-carotene are associated with a reduced risk of cardiovascular disease Rimm et al, 1993; Kardinaal et al, 1993; Riemersma et al, 1991; Gale et al, 1995; Knekt et al, 1994; Kushi et al, 1996) and a recent intervention study demonstrated that a-tocopherol supplementation reduced the rate of non-fatal myocardial infarction in patients with coronary atherosclerosis (Stephens et al, 1996) . In addition, dietary intake of¯avonoids, antioxidants which mainly occur in vegetables, tea and wine, have recently also been shown to be inversely associated with mortality from coronary heart disease (Hertog et al, 1993; Knekt et al, 1996) .
The evidence from animal studies that antioxidants possess anti-atherogenic properties has been summarized by Daughterty & Roselaar (1995) . In addition to animal studies, the effect of high doses of vitamin E and bcarotene on the resistance of LDL to oxidation has been investigated extensively in humans in short-term intervention studies. Supplementation with 100±1600 mg vitamin E per day has consistently been shown to increase the resistance of LDL to oxidation ex vivo Jialal & Grundy, 1992; Princen et al, 1992; Reaven et al, 1993; Jialal et al, 1995; Jialal & Grundy, 1993) and lower doses also seem to be effective. Princen et al (1995) showed that vitamin E intake at a dose as low as 25 mg/d (2.5 times the recommended daily allowance, (Food and Nutrition Board, 1989) ) signi®cantly increased the duration of the lag phase before LDL oxidation ex vivo. On the other hand, Jialal et al (1995) found that only vitamin E doses of 400 mg/d and higher were effective. Supplementation with high doses of b-carotene or vitamin C does not seem to increase the resistance of LDL to oxidation (Reaven et al, 1993) .
Atherogenesis is a multifactorial disease and combinations of antioxidants may be particularly effective in reducing the risk of cardiovascular disease. Synergistic effects may occur between different antioxidants because of differences in lipophilicity and thus the site of free radical scavenging activity may be in the LDL particle or intracellularly. Synergism has been found between vitamin C and E due to regeneration of vitamin E by vitamin C (Sato et al, 1990) . However, there is currently little knowledge on the bene®cial effects of combinations of antioxidants and in particular little is known of the effects of lower doses of mixtures of these compounds that can be achieved by dietary means.
Therefore, the effect of consumption of moderate doses of a combination of antioxidants, incorporated into a habitually used food product, on the body's antioxidant status and on parameters of oxidative damage to lipids was assessed. A full-fat margarine, forti®ed with 31 mg/d vitamin E, 121 mg/d vitamin C, 2.7 mg/d a-carotene and 5.3 mg/d b-carotene, was used as vehicle to supply the antioxidants. These daily amounts equalled two to three times the recommended daily intake for vitamin C and E (Food and Nutrition Board, 1989) and about two times the average intake of b-carotene (Yong et al, 1994) and are in line with optimal intake levels recently proposed by Lachance (1996) .
Subjects and methods

Volunteers
Non-smoking subjects, healthy as assessed by a medical investigation, between 18 and 65 y old, were eligible for participation in the study. The volunteers did not use vitamin C, E, carotenoid, selenium or zinc supplements. Subjects were not using a medically prescribed diet or slimming regime and had been weight-stable for at least one month prior to the start of the study. Females were not pregnant or lactating. Volunteers were recruited from employees of our laboratory and from inhabitants of Vlaardingen and the surrounding district. Subjects gave their written informed consent prior to participation.
Study design
After a two week run-in period during which time subjects consumed 15 g/d of an ordinary (control) margarine, 32 volunteers either continued to consume the control margarine or started to consume 15 g/d of an antioxidant forti®ed margarine, providing 121 mg vitamin C, 31 mg vitamin E, 2.7 mg a-carotene and 5.3 mg b-carotene, during the next four weeks. Volunteers were allocated to either of the two treatment groups, taking into account an equal distribution of sex, age and Quetelet Index. Due to the difference in colour of the margarines, the study was only blind to the analysts analysing the blood samples. The effects of consumption of the antioxidant forti®ed margarine on plasma and LDL antioxidant status, LDL-resistance to oxidation and markers of in vivo oxidative damage to lipids were evaluated. In addition, we calculated the contribution of individual antioxidants to parameters of the total antioxidant activity of plasma and LDL. For this part of the study, we used the initial values measured in plasma and LDL of volunteers from the present study and of volunteers from a study which was executed at the same time (Van het Hof et al, 1997) . The protocol of the study was approved by our local Research Ethics Committee.
Based on data of Abbey et al (1993a) , we calculated that a number of 16 volunteers per group would be suf®cient to detect a difference of 13% in changes in resistance of LDL to copper-induced oxidation (lag phase) between both groups (a 0.05; b 0.10).
Experimental margarines
The full-fat margarines were prepared in our laboratory. Ascorbic acid (L()-ascorbic acid, Merck, Darmstadt, Germany), a-tocopherol (L-a-tocopherol, Merck, Darmstadt, Germany) and natural palm carotene, containing a-carotene and b-carotene (30% suspension in corn oil, Quest International, Naarden, The Netherlands), were added to the antioxidant forti®ed margarine. Fat content (82%) and fatty acid composition were similar in the control and antioxidant forti®ed margarine. Volunteers consumed 15 g/d of either the control or antioxidant forti®ed margarine. This daily amount of the antioxidant forti®ed margarine contained 121 mg ascorbic acid, 31.1 mg a-tocopherol, 2.7 mg a-carotene and 5.3 mg b-carotene. The control margarine contained no ascorbic acid, no carotenoids and 0.97 mg atocopherol/15 g margarine. The daily amounts of vitamins C and E provided by the forti®ed margarine equalled two and three times the RDA of vitamin C and vitamin E respectively (Food and Nutrition Board, 1989) whereas the daily amount of b-carotene was similar to the amount advised by the National Cancer Institute in the United States (Lachance, 1988) .
Lifestyle and dietary intake
Volunteers were requested to maintain their habitual lifestyle during the entire experiment. They were instructed to replace their habitual margarine on bread products by the supplied margarine and not to use the margarine for baking or frying. Changes in dietary intake of vitamin C, E and carotenoids were assessed by a self-completed food frequency questionnaire at the start and at the end of the study. The food frequency questionnaire was validated for carotenoid intake (Weststrate & van het Hof, 1995) and vitamin C intake (Pearson's coef®cient of correlation between estimated intake and plasma levels r 0.60, P 0.0001).
Plasma and LDL-analyses
Fasting venous blood samples were taken once before and once at the end of the experimental period and collected into Na 2 EDTA coated tubes for plasma and into plain tubes for serum preparation. Plasma and serum were prepared by low-speed centrifugation. Plasma used for the analysis of ascorbic acid was treated with trichloro-acetic acid (150 mmol/L ®nal concentration) immediately after preparation to prevent degradation of ascorbic acid. Plasma samples for LDL isolation were stabilized with 6 g/L sucrose, immediately frozen in liquid nitrogen and stored at 770 C. It has been established that freezing LDL in this way does not in¯uence oxidation parameters . LDL was isolated from thawed plasma by discontinuous density gradient ultracentrifugation for 24 h at 4 C (Redgrave et al, 1975) . The LDL fraction (density 1.019± 1.063 g/ml) for the analysis of LDL a-tocopherol, a-carotene, b-carotene and lipid hydroperoxides was stored at 770 C. Immediately following LDL isolation, LDL protein content was determined using bovine serum albumin (Fraction V, Sigma, St. Louis, Mo., USA) as the standard (Markwell et al, 1978) and in vitro oxidation studies were carried out thereafter. Serum was stored at 720 C for the analysis of lipids.
a-Tocopherol, a-carotene and b-carotene were determined in plasma and LDL. After addition of appropriate internal standards (a-tocopherol-acetate and ethyl-apo-b Hcarotenoate), extraction was performed with n-heptane and n-heptane/diethyl ether (1:1, v/v). Following evaporation of the solvents, the residue was dissolved in eluent and atocopherol, a-carotene and b-carotene were separated by reversed phase HPLC using 201 TP54 Vydac column (Separations Group, Hesperia CA, USA) and methanol/ tetrahydrofuran/ammonium acetate solution (1 g/L) (95:5:2, v/v) as mobile phase at a¯ow rate of 0.8 ml/min and a column temperature of 13 C Epler et al, 1992) . Vitamin C concentration in trichloroacetic acid-treated plasma was determined¯uorimetrically as ascorbic acid plus dehydroascorbate as described by Vuilleumier & Keck (1989) . Albumin, bilirubin, uric acid, total cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol were determined in serum using enzymatic colorimetric methods (Boehringer Mannheim, Germany). Total antioxidant activity in plasma (Miller et al, 1993) and in LDL (Miller et al, 1995) were determined by the ABTS/ ferryl myoglobin assay using reagents of Randox Diagnostics (County Antrim, UK). Results are expressed relative to Trolox (Randox Diagnostics, County Antrim, UK). The inter assay variation was 3% for plasma total antioxidant activity. Malondialdehyde was determined in plasma after complexation with diethylthiobarbituric acid. The malondialdehyde-thiobarbituric acid adduct was separated from interfering substances by HPLC essentially as described previously (Wong et al, 1987) and the adduct was detected uorimetrically using an excitation wavelength of 538 nm and emission wavelength of 554 nm. LDL lipid hydroperoxides were determined as previously described (Wieland et al, 1992) . The resistance of LDL to oxidation was determined by monitoring the production of conjugated dienes during copper-mediated LDL oxidation as described previously (Princen et al, 1992) . To minimize effects due to between assay variability, LDL samples from the same subject, before and after the treatment period, were analyzed in the same run. The inter assay variation was 10% for the lag phase and 4% for the maximum rate of oxidation.
Statistical analyses
Data were analyzed using SAS computer software (Statistical Analysis System Institute, 1987) . Plasma and LDL concentrations of a-carotene and b-carotene were log-transformed to minimize correlation between mean values and standard errors within the treatment groups. All comparisons were made at the two-sided 0.05 signi®cance level. Data was analyzed using ANOVA with treatment, time, subject (within treatment) and the treatment±time interaction as effects. Means are presented with standard error (CVM if log-transformation was applied). Treatment±time effects are presented as difference between the time changes within the treatment groups with 95% con®dence interval. In case of logtransformation these values are expressed as percentage of the time change within the control group. Plasma concentrations of vitamin E, a-and b-carotene, normalized for serum cholesterol and triacylglycerol levels, were also analyzed for differences in changes between the treatments (vitamin E, a-or b-carotene concentration/(cholesterol triacylglycerol concentration)).
Stepwise multiple linear regression analysis was used to analyze the relation between plasma total antioxidant activity as dependent variable and plasma concentrations of vitamin C, vitamin E, a-carotene, b-carotene, albumin, bilirubin and uric acid as independent variables as well as the relation between total antioxidant activity of LDL and LDL concentrations of vitamin E, a-carotene and b-carotene. Stepwise multiple linear regression analysis was also used to analyze the relation between the resistance of LDL to oxidation (duration of lag phase and maximum rate of oxidation) and the concentrations of the above mentioned, lipophilic antioxidants in LDL. The total number of observations included was 49±60, depending on the number of missing data for each parameter.
Results
Fifteen men and sixteen women completed the study. The volunteer who withdrew from participation in the study did so for medical reasons not related to the experimental treatment. Table 1 shows descriptive statistics of the volunteers who completed the study. The volunteers ranged in age from 18±57 y.
Compliance to treatment Treatment compliance of the volunteers, as monitored by assessment of unused tubs of margarine, was very good. More than 99.5% of the provided margarine was consumed in both treatment groups. The average intake of margarine was 15.2 g/d (s.e.m. 0.03). Changes in dietary intake of vitamin E, vitamin C and carotenoids were calculated without the antioxidants supplied by the forti®ed margarine. The estimated intake of most of the antioxidants investigated showed a signi®cant decrease during the study in both treatment groups (Table  1) . However, no signi®cant differences in changes between the treatment groups were found. Table 2 shows the effect of consumption of antioxidant forti®ed margarine on plasma concentrations of vitamin E, a-carotene, b-carotene, vitamin C, albumin and uric acid and the total antioxidant activity of plasma. LDL concentrations of vitamin E, a-carotene and b-carotene and total antioxidant activity of LDL are shown in Table 3 . Daily consumption of the antioxidant forti®ed margarine signi®-cantly increased plasma levels of vitamin E by 16% as compared to the consumption of a control margarine. In LDL vitamin E concentration increased by 22%, but this increase was not signi®cantly different from that found in the control group. Intake of the antioxidant forti®ed margarine resulted in a 15% increase in the plasma vitamin C level. The effect of consumption of the antioxidant forti®ed margarine was most striking with regard to blood levels of a-carotene and b-carotene. As compared to the control group, a-carotene levels showed a 14.5-fold increase in plasma and a 15.5-fold increase in LDL. b-Carotene concentration was increased 3.4-fold in plasma and 4.3-fold in LDL.
Plasma and LDL antioxidant status
Because the mean change in serum levels of total cholesterol and triacylglycerol were not signi®cantly different between the treatment groups (data not shown), the differences between the treatment groups in changes of plasma concentration of vitamin E, a-and b-carotene normalized for serum lipids (data not shown) were comparable to the differences between changes of plasma concentrations as such. Plasma concentrations of the endogenous components with antioxidant activity, albumin and uric acid, were not affected by the treatments (Table 2) .
Consumption of the antioxidant forti®ed margarine did not signi®cantly alter the total antioxidant activity of plasma as determined by the ABTS/ferryl myoglobin assay ( Table 2 ). The total antioxidant activity of LDL from the antioxidant-treated subjects was signi®cantly higher at the end of the study as compared to the initial value, but this change was not signi®cantly different from the change in the subjects who had consumed control margarine (Table 3) .
Malondialdehyde and lipid hydroperoxides were measured as markers of oxidative stress in vivo as these compounds are breakdown products of lipid peroxidation. Supplementation with the margarine forti®ed with vitamin C, vitamin E, a-carotene and b-carotene did not affect the concentration of malondialdehyde in plasma (difference between changes (95% CI): 70.09 mmol/L (70.34, 0.16)) nor that of lipid hydroperoxides in LDL (difference between changes (95% CI): 0.12 nmol/L LDL (71.23, 1.46)).
The resistance of LDL to copper-induced oxidation was assessed by measurement of the lag phase before oxidation and the maximum rate of oxidation. The lag phase before oxidation was signi®cantly increased after four weeks of consumption of antioxidant forti®ed margarine as compared to baseline values. No signi®cant difference in changes was found however between the two treatment groups. The maximum rate of oxidation decreased signi®-cantly when the antioxidant forti®ed margarine was consumed, and the difference of this change compared to the change found in the control group was of borderline signi®cance.
To establish the contribution of individual antioxidants to the total antioxidant activity, we determined the regression line between the status of vitamin C, vitamin E, acarotene, b-carotene, albumin (g/L), bilirubin (mmol/L) and uric acid (mmol/L) in plasma and LDL and the total antioxidant activity of plasma and LDL. For this purpose, we combined the initial values from the present study (n 31) (Tables 2 and 3) . Vitamin E was the main contributor to the total antioxidant activity of LDL, explaining 79% of the variance. A higher level of acarotene in LDL, however, was associated with a decreased total antioxidant activity of LDL.
In addition, the relation between the LDL antioxidant levels and the resistance of LDL to oxidation was assessed by stepwise multiple linear regression analysis. The concentration of a-carotene in LDL appeared to be inversely associated with the lag phase before oxidation of LDL, with an explained variance of only 9% (equation: lag phase 104.2±0.15 [a-carotene] LDL ). The LDL levels of vitamin E, a-carotene and b-carotene were not signi®cantly associated with the maximum rate of oxidation.
Discussion
In the present study the effects of 4-weeks supplementation with an antioxidant forti®ed margarine on the body's antioxidant status and LDL oxidizability were investigated. The forti®ed margarine contained a mixture of different fatsoluble (vitamin E, a-carotene, b-carotene) and watersoluble antioxidants (vitamin C) in amounts equivalent to two to three times the recommended intakes or average daily intake. The results show that daily consumption of this antioxidant forti®ed margarine induces signi®cant increases in both plasma and LDL levels of the supplied antioxidants.
Supplementation with 121 mg/d of vitamin C resulted in a 15% increase of plasma levels of vitamin C. Due to a tight regulation of the vitamin C status, the response to supplementation with vitamin C is dependent on the vitamin C status of the body before supplementation (Levine et al, 1996) . Depending on the vitamin C status of the volunteers and the size of the doses (600 mg/d±2 g/d), increases in plasma concentrations of 25±275% have been found previously (Reaven et al, 1993; Jialal & Grundy, 1993; Abbey et al, 1993b; Salonen et al, 1991) . Final concentrations reported in these studies were between 75 and 85 mmol/L and thus very similar to the concentration of 77 mmol/L we found at the end of our study in the antioxidant forti®ed margarine group. This indicates that consumption of moderate amounts of vitamin C is suf®cient to achieve saturation levels of plasma vitamin C and that, quite surprisingly, a full-fat margarine is a good carrier for supplementation with water-soluble compounds.
In addition to vitamin C which functions as a watersoluble antioxidant, we supplied moderate amounts of fatsoluble antioxidants, namely vitamin E, a-carotene and bcarotene. The plasma levels of vitamin E increased by 16% after supplementation with 31 mg/d vitamin E, which is comparable to the 20% increase after supplementation during two weeks with 25 mg/d of vitamin E that has been reported previously (Princen et al, 1995) .
An important ®nding of the present study is that margarine is an excellent vehicle for carotenoid supplementation. Our data show that 2.7 mg/d of a-carotene and 5.3 mg/d of b-carotene incorporated in margarine resulted in respectively 14.5 and 3.4-fold increases in plasma levels of these carotenoids. It has been shown in previous studies that, in comparison with plasma levels of vitamin E and vitamin C, plasma carotenoid concentrations are most sensitive to supplementation (Jialal & Grundy, 1993; Abbey et al, 1993b; Salonen et al, 1991) . The increases in carotenoid concentrations observed in the present study also exceed the 2.6-fold increase in a-carotene and 1.9-fold increase in b-carotene levels in plasma found by Carughi & Hooper (1994) after four weeks supplementation with slightly higher doses of carotenoids (3.5 mg/d a-carotene and 8.5 mg/d b-carotene). Abbey et al (1993b) reported a 5-fold increase in plasma b-carotene after three months of supplementation with b-carotene at a dose of 18 mg/d. All of these data pertain to well-nourished individuals. De Pee et al (1995) showed that in anaemic women, 12 weeks supplementation with 3.5 mg/d b-carotene resulted in a 3.9-fold increase in serum b-carotene levels and a 1.4-fold increase in serum retinol levels.
Interestingly, the increase of plasma levels of a-carotene exceeded that of b-carotene. The ®nal concentration of acarotene in plasma and in LDL was similar to that of bcarotene, although the intake of a-carotene was only 50% of that of b-carotene. This is in contrast with Carughi & Hooper (1994) who found that the ratio of ®nal plasma concentrations of a-carotene and b-carotene was the same as the supplemented ratio. One possible explanation for our results is that the bioavailability of a-carotene is higher than that of b-carotene. This is however not likely because Van den Berg (personal communication) found no difference after consumption of a single dose of either a-or bcarotene in chylomicron concentration response. It is also possible that the metabolism of a-carotene is slower than that of b-carotene. Both a-and b-carotene have provitamin A activity and in vitro experiments have shown that retinal formed from a-carotene was only 29% of the amount formed from equal amounts of b-carotene (Van Vliet et al, 1996) . These results support the suggestion of a lower turn-over rate of a-carotene as compared to b-carotene. It is also possible that the rate of oxidative degradation of bcarotene is higher than that of a-carotene or that a quantitative difference in tissue distribution of a-and b-carotene has contributed to the difference in blood levels, but there are no data available to support these hypotheses.
Despite the observed increase in blood levels of individual antioxidants after supplementation with the antioxidant forti®ed margarine, no signi®cant treatment effect on total antioxidant activity of plasma was found. The total antioxidant activity of plasma re¯ects the`sum' of endogenous and dietary antioxidants in plasma and is mainly determined by the concentration of albumin and uric acid (Miller et al, 1993; Wayner et al, 1987) . However, only 19% of the variation in total antioxidant activity of plasma appeared to be explained by the variation in concentration of these two endogenous antioxidants. Apparently, variation in plasma levels of other than the measured antioxidants determine the between subject variation in the total antioxidant activity of plasma. Plasma concentrations of albumin and uric acid were unchanged in both treatment groups. The magnitude of the changes in dietary antioxidant concentrations in plasma may have been too small to signi®cantly increase the total antioxidant activity of plasma in the antioxidant forti®ed margarine group.
In addition to measurement of the total antioxidant activity of plasma, the total antioxidant activity of the LDL particles was assessed. LDL mainly contains fatsoluble components and we found a signi®cant contribution of all of the supplied fat-soluble antioxidants to LDL antioxidant activity at baseline. LDL antioxidant activity increased signi®cantly in the antioxidant forti®ed margarine group compared to baseline and the difference with the change found in the control group almost reached signi®-cance (P 0.08). This indicates that supplementation with a combination of the fat-soluble antioxidants vitamin E, aand b-carotene, in dosages comparable to those used in the present study, may increase the protection of LDL to oxidative stress in vivo.
Despite signi®cant increases in the antioxidant levels in plasma and LDL and the LDL antioxidant activity, no alteration of the lipid peroxidation products malondialdehyde in plasma and lipid hydroperoxides in LDL was found. It is however conceivable that effects of antioxidant supplementation on lipid peroxidation are detectable only in subjects exposed to increased levels of oxidative stress, for example in heavy smokers. Allard et al (1994) showed that daily supplementation with 20 mg b-carotene for four weeks reduced lipid peroxidation in smokers but not in non-smokers. Our results are in agreement with those of Allard et al (1994) and with those of Abbey et al (1993b) , who also found no change of malondialdehyde levels in LDL of non-smoking subjects after six months of dietary supplementation with a combination of a-tocopherol (200 mg/d), b-carotene (18 mg/d) and vitamin C (900 mg/d).
Consumption of the antioxidant forti®ed spread for four weeks tended to increase the resistance of LDL to oxidation as compared to the changes found in the control group. Both the lag time as well as the maximum oxidation rate were signi®cantly affected as compared to baseline in the forti®ed margarine group. This is in line with Princen et al (1995) who also found that supplementation with 25 mg/d vitamin E signi®cantly increased the lag time of LDL oxidation as compared to baseline. In the latter study, the maximum rate of oxidation was however only affected if 400 mg/d or more of vitamin E was consumed. This lower sensitivity of the oxidation rate to increased antioxidant status was also observed by Jialal et al (1995) . In their study, the oxidation rate was affected only after supplementation with 800 mg/d vitamin E, whereas the lag time was signi®cantly increased as compared to baseline after supplementation with 400 mg/d but not after supplementation with 60 or 200 mg/d vitamin E. It is possible that the greater effectiveness of antioxidant supplementation found in the present study is due to the combination of antioxidants supplied to the volunteers. Not only did the vitamin E status increase signi®cantly but also the concentrations in plasma and LDL of a-and b-carotene and the plasma concentration of vitamin C were increased in the antioxidant forti®ed margarine group. For the lag time, however, an inverse correlation was found with a-carotene level in LDL. The a-carotene concentration explained only 9% of the variation in the duration of the lag phase and this may be the reason that the increase in LDL concentration of acarotene in the forti®ed margarine group did not abolish the protective effect of the other antioxidants. The role of acarotene in the protection of LDL against oxidation in vitro has not yet been investigated, whereas for b-carotene Esterbauer et al (1991) have shown that this carotenoid is used sequentially to vitamin E as protective barrier to LDL oxidation. Furthermore they showed that vitamin C, when added to LDL, was oxidized even before vitamin E and b-carotene. Previous studies in which different antioxidants were supplemented showed no additional protective effects of b-carotene and vitamin C as compared to supplementation with vitamin E alone (Princen et al, 1992; Reaven et al, 1993; Jialal & Grundy, 1993) . However, the pharmacological doses of vitamin E used in these studies may have masked the protective effects of the other antioxidants.
Vitamin C can protect against oxidative stress both by its role as antioxidant defence against aqueous radicals (Jialal & Grundy, 1991) as well as by regenerating vitamin E from the vitamin E radical at the water-lipid interface of LDL as has been observed in vitro (Sato et al, 1990) . The role of a-and b-carotene as antioxidants is however still not elucidated. The inverse correlation we found between the level of a-carotene in LDL and both the LDL antioxidant activity and the duration of the lag phase before LDL oxidation does not support the hypothesis that this carotenoid protects against cardiovascular disease by increasing intrinsic LDL antioxidant protection. However, the resistance of LDL to oxidation in vitro is only one suggested biomarker of the risk of cardiovascular disease and the role of carotenoids in the process of atherogenesis has recently been suggested to be mediated by conversion into retinoic acid rather than via protection of LDL against oxidation (Shaish et al, 1995) .
Conclusions
The results of our study clearly show that consumption of moderate doses of vitamin E, vitamin C, a-carotene and bcarotene, supplied at two to three times the RDA in a fullfat margarine and consumed as part of a normal diet, effectively increases the blood levels of these antioxidants to achieve threshold plasma levels that have been suggested for optimal health (Gey et al, 1995) .
